4Suppliers
4Customers
3Debt Items
4Related Chains

Source-Backed Evidence Depth

Pulmatrix, Inc. (PULM) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

11Total relationships
3Distinct source URLs
7High confidence
0.838Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Pulmatrix, Inc. Suppliers

TickerNameConfidenceEvidence
EOS Eaton Vance Enhanced Equity Income Fund II 90% Eos entered into a Securities Purchase Agreement, dated as of March 26, 2026 (the “ Eos Purchase Agreement ”), with an affiliate of Eos for the purchase and sale of certain convertible promissory notes
EOS Eaton Vance Enhanced Equity Income Fund II 90% Reciprocal relationship from EOS graph: Reciprocal relationship from PULM graph: Reciprocal relationship from EOS graph: Reciprocal relationship from PULM graph: Reciprocal relationship from EOS grap…
MNKD MannKind Corporation 72% primarily of costs incurred for the research and development of our preclinical and clinical candidates, and include: ● employee-related expenses, including salaries, benefits and stock-based compens…
MNKD MannKind Corporation 72% Reciprocal relationship from MNKD graph: Reciprocal relationship from PULM graph: primarily of costs incurred for the research and development of our preclinical and clinical candidates, and include:…

Pulmatrix, Inc. Customers

TickerNameConfidenceEvidence
EOS Eaton Vance Enhanced Equity Income Fund II 92% Pulmatrix entered into a Securities Purchase Agreement with an affiliate of Eos (the “ Buyer ”), pursuant to which Pulmatrix agreed to sell to the Buyer an aggregate of 1,000 shares of Series B Conve…
EOS Eaton Vance Enhanced Equity Income Fund II 92% Reciprocal relationship from EOS graph: Reciprocal relationship from PULM graph: Pulmatrix entered into a Securities Purchase Agreement with an affiliate of Eos (the “ Buyer ”), pursuant to which Pul…
MNKD MannKind Corporation 72% elopment services for the Product and $ million for the irrevocable license to the Assigned Assets. Any consideration related to the Co-Development Phase was not initially included in the transaction…
MNKD MannKind Corporation 72% Reciprocal relationship from MNKD graph: Reciprocal relationship from PULM graph: Reciprocal relationship from MNKD graph: Reciprocal relationship from PULM graph: Reciprocal relationship from MNKD g…

Pulmatrix, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
PULM-DEBT-11952 Warrants outstanding: 535830 90% xbrl warrant detail from xbrl 2025-12-31.
PULM-DEBT-11953 Xbrl Convertible 90% xbrl convertible detail from xbrl 2015-12-31.
PULM-DEBT Debt stack $1.8M 90% Market cache reports total debt of $1.8M.

Pulmatrix, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Pulmatrix, Inc..

Pulmatrix, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for Pulmatrix, Inc..

Pulmatrix, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
EOS Eaton Vance Enhanced Equity Income Fund II 100.00 1 ['customer', 'supplier']
MNKD MannKind Corporation 100.00 1 ['customer', 'supplier']
BDRX Biodexa Pharmaceuticals Plc 50.00 2
AMPH Amphastar Pharmaceuticals, Inc. 50.00 2
🔐
PULM
Unlock PULM Supply Chain Data
Verified relationships include:
EOSEaton Vance Enhanced Equi…Supplier90%
EOSEaton Vance Enhanced Equi…Supplier90%
EOSEaton Vance Enhanced Equi…Customer92%
EOSEaton Vance Enhanced Equi…Customer92%
+7 more relationships locked
Subscribe, View plans →